Dr. Ronald Mark Gemberling, MD Surgery - Plastic and Reconstructive Surgery Medicare: Not Enrolled in Medicare Practice Location: 3803 S Bascom Ave, Suite 204, Campbell, CA 95008 Phone: 408-559-8658 Fax: 408-559-8678 |
Michael John Cummins, M.D. Surgery - Vascular Surgery Medicare: Not Enrolled in Medicare Practice Location: 802 Rue Montagne, Campbell, CA 95008 Phone: 408-371-0193 |
Dr. Antoine Lyonel Carre, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 958 La Plata Plz, Campbell, CA 95008 Phone: 408-230-6654 |
Bradley B. Hill, MD Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 3803 S Bascom Ave Ste 204, Campbell, CA 95008 Phone: 408-770-4455 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with ALN-AT3, a subcutaneously administered RNAi therapeutic targeting antithrombin (AT) for the treatment of hemophilia and rare bleeding disorders (RBD), at the 55th Annual Meeting of the American Society of Hematology (ASH) held December 7 - 10, 2013 in New Orleans.
One Call Medical, Inc. (OCM), the nation's leading provider of specialty services to insurance payers, today announced its acquisition of Raytel Imaging Network, Inc. (RIN), a preferred provider network of diagnostic imaging services, including MRIs and CT scans. This acquisition expands and strengthens OCM's market-leading national diagnostic network.
Travel bans have been key to efforts by many countries to control the spread of COVID-19. But new research aimed at providing a decision support system to Italian policy makers, recently published in the Journal of the Royal Society Interface, suggests that reducing individual activity (i.e., social distancing, closure of non-essential business, etc.) is far superior in controlling the dissemination of Sars-CoV-2, the virus that causes COVID-19.
Amgen today announced that it will present data from several key Nplate (romiplostim) studies at the 52nd Annual Meeting and Exposition of the American Society of Hematology (ASH), Dec. 4-7, 2010, in Orlando, Fla.
Researchers showed that 20-50% of patients developed an irregular heartbeat that required defibrillation during the active cooling phase of therapeutic hypothermia following an out-of-hospital cardiac arrest.
› Verified 9 days ago